Literature DB >> 3981309

Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection.

M Hadchouel, A M Prieur, C Griscelli.   

Abstract

Seven children with juvenile rheumatoid arthritis had a syndrome characterized by hemorrhage and neurologic, hepatic, hematologic, and metabolic manifestations. The disease did not seem to conform clearly to the characteristics of Reye syndrome or any other well-known entity. This severe complication may be induced by macrophage activation secondary to a drug or intercurrent infection. Our data suggest that a sudden fall in erythrocyte sedimentation rate or in platelet and fibrinogen levels may mark the start of this complication and may be an indication for rapid steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981309     DOI: 10.1016/s0022-3476(85)80072-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  53 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.

Authors:  Mark Gorelik; Kathryn S Torok; Daniel A Kietz; Raphael Hirsch
Journal:  J Rheumatol       Date:  2011-02       Impact factor: 4.666

3.  Characteristics of bone marrow cells in 107 patients with juvenile idiopathic arthritis: A retrospective study.

Authors:  Di Zhu; Jihua Zhong; Yiwei Zhang; Fangyuan Chen
Journal:  Exp Ther Med       Date:  2018-08-01       Impact factor: 2.447

Review 4.  Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 5.  [Still's disease in children and adults].

Authors:  C M Hedrich; C Günther; M Aringer
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 6.  Histiocytoses.

Authors:  J L Stéphan
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

7.  Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis.

Authors:  Mina Hur; Young Chul Kim; Kyu Man Lee; Kwang Nam Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

8.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

9.  Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report.

Authors:  Chan-Ran You; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.